Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Chang-Hoon | - |
dc.contributor.author | Kim, Jin Kook | - |
dc.contributor.author | Kim, Hyun Jun | - |
dc.contributor.author | Cho, Jin Hee | - |
dc.contributor.author | Kim, Jung-Soo | - |
dc.contributor.author | Kim, Yong-Dae | - |
dc.contributor.author | Lee, Heung-Man | - |
dc.contributor.author | Kim, Sung Wan | - |
dc.contributor.author | Cho, Kyu-Sup | - |
dc.contributor.author | Lee, Sang Hag | - |
dc.contributor.author | Rhee, Chae-Seo | - |
dc.contributor.author | Dhong, Hun-Jong | - |
dc.contributor.author | Rha, Ki-Sang | - |
dc.contributor.author | Yoon, Joo-Heon | - |
dc.date.accessioned | 2021-09-04T18:39:02Z | - |
dc.date.available | 2021-09-04T18:39:02Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-03 | - |
dc.identifier.issn | 2092-7355 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94254 | - |
dc.description.abstract | Purpose: To evaluate the efficacy and safety of once-daily ciclesonide in comparison to both levocetirizine alone, and a ciclesonide/levocetirizine combination in patients with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). Methods: Subjects exhibiting moderate to severe allergic rhinitis for longer than 1 year were randomized in an open-label, 3-arm, parallel group, multicenter study. Subjects received 200 mu g ciclesonide, 5 mg levocetirizine, or a combination of both. Changes from baseline until the end-of-study visit (2 weeks following) were evaluated by reflective total nasal symptom scores (rTNSSs), reflective total ocular symptom scores (rTOSSs), physician-assessed overall nasal signs and symptoms severity (PANS), and rhinoconjunctivitis quality-of-life questionnaires (RQLQ). Results: Significant improvements in rT.NSS, PANS, and RQLQ in the ciclesonide monotherapy group were observed in comparison to the levocetirizine alone group. Three individual symptoms of rTNSS, including runny nose, nasal itching, and congestion, were improved in the ciclesonide-treated group. rTOSS scores for ciclesonide monotherapy improved from baseline, but no superiority over levocetirizine was shown. The absolute score and changes in rTNSS and PANS were positively correlated. Ciclesonide spray was more effective than levocetirizine in reducing nasal symptoms in both SAR and PAR patients. Ciclesonide and levocetrizine were well tolerated alone and in combination. Conclusions: Our results provide support for an AR and its Impact on Asthma (ARIA) recommendation stipulating that ciclesonide is superior to levocetirizine for the treatment of AR, with tolerable safety. Addition of levocetirizine to ciclesonide did not give further clinical benefit over monotherapy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY | - |
dc.subject | PERSISTENT ASTHMA | - |
dc.subject | NASAL AEROSOL | - |
dc.subject | EFFICACY | - |
dc.subject | CLASSIFICATION | - |
dc.subject | GUIDELINE | - |
dc.subject | DIAGNOSIS | - |
dc.subject | ADULTS | - |
dc.title | Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Heung-Man | - |
dc.contributor.affiliatedAuthor | Lee, Sang Hag | - |
dc.identifier.doi | 10.4168/aair.2015.7.2.158 | - |
dc.identifier.scopusid | 2-s2.0-84937854443 | - |
dc.identifier.wosid | 000358824400009 | - |
dc.identifier.bibliographicCitation | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, v.7, no.2, pp.158 - 166 | - |
dc.relation.isPartOf | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.citation.title | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.citation.volume | 7 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 158 | - |
dc.citation.endPage | 166 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001963082 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Allergy | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Allergy | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | PERSISTENT ASTHMA | - |
dc.subject.keywordPlus | NASAL AEROSOL | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | GUIDELINE | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordAuthor | Allergic rhinitis | - |
dc.subject.keywordAuthor | ciclesonide | - |
dc.subject.keywordAuthor | levocetirizine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.